Gang-Ming Zou, MD, Ph.D.
American Journal of Translational Medicine.
1170 Nuuanu Ave, Suite 37974.
Honolulu HI 96837, USA.
Senior Editor (Molecular Pathology):
Victor Lobanenkov, MD, Ph.D.
Molecular Pathology Section. NIAID. NIH. Bethesda. USA
Associate Editor ((Tissue engineering and regenerative medicine):
Qingfeng Li, MD., Ph.D.
Shanghai Ninth People's Hospital,
Shanghai Jiao Tong University, China
Associate Editor (Neuroscience):
Aihua Liu, MD, Ph, D
Department of Neurosurgery,
Beijing Tiantan Hospital,
Beijing Capital Medical University, Beijing,China
Section Editor (Translational Oncology)
Zhiqian Hu, MD, Ph.D.
Shanghai Changzheng Hospital.
Shanghai. 200003. China.
Section Editor (Case report)
Jinlei Lv, M.D, Ph.D.
Nanchang University. Nanchang, China
Editorial Advisory Board:
Richard Allsopp, Ph.D. The University of Hawaii. Honolulu, HI, USA
Arvind Chhabra, MD, Ph.D. Amity University Haryana. Gurgaon, India.
Xiangfeng Chen, MD, Ph.D. Shanghai Jiao Tong University, Shanghai, China
Jianjun Chen, MD, PhD, Tongji University. Shanghai. China.
Hai-Yan Dai, MD, Shanghai Pudong Hospital, Shanghai 201388, China.
Gines Escolar, MD, University of Barcelona, Barcelona, Spain.
Jesuss Espada, PhD Ramon Y Cajal University Hospital, Madrid, Spain
Cunyi Fan, MD, Ph.D., Shanghai Jiao Tong University, Shanghai, China
Caixia Guo, MD, PhD. Beijing Tongren Hospital, Capital Medical University, Beijing, China
Fabin Han, MD, Ph.D. Liaocheng University. Liaocheng, China
Wen-Yang Hu, MD, Ph.D., the University of Illinois at Chicago, Chicago, USA
Hongjun Jin, Ph.D. Sun Yat-sen University, 5th Hospital, Zhuhai, China
Vipin Kumar, Ph.D., University of California San Diego. USA
Yan Lei, MD Ph.D. Sun Yat-sen University, 7th Hospital, Shenzhen, China
Rui Li, Ph.D. Tsinghua University, China
Zunjing Liu, MD, PhD. Peking University Health Science Center
Xi-Dai Long, MD., Ph.D., Guangxi University. Nanning, Guangxi. China.
Roy Rillera Marzo, MD, Asia Metropolitan University, Johor, Malaysia
Jaroslav Michalek, MD, Motol University Hospital. Brno, Czech Republic
Nathan Newman, MD, Rinati Skin, LLC, Los Angeles, CA, USA
Michel Petitjean, MD, Ph.D., University Paris 7, Paris, France
Zhi-Yong Qin, MD, Ph.D. Huashan Hospital, Fudan University. Shanghai, China.
Yi Shao, MD, The First Affiliated Hospital, Nanchang University, Nanchang, China
Daniel Scherman, PhD. CNRS, UTCBS UMR 8258, F-75006, Paris, France.
Huaizhang Shi, MD, PhD, Harbin Medical University, Harbin, China
Zhiwei Sun, MD, Ph.D. Kunming University of Science and Technology, Kunming, China
Georges Uzan, PhD, INSERM U972, Hôpital Paul Brousse, Villejuif, France.
Bing Hui Wang, Ph.D. Baker Heart and Diabetes Institute. Melbourne. Australia.
Zhenzhong Zheng, MD, Ph.D., Nanchang University. Nanchang, China
Hua Zhang, MD, Ph.D. Peking Union Medical College. Beijing, China
Charles Zhao, PhD. Southern University of Science and Technology, Shenzhen, China
Liaonan Zou, MD, Ph.D., Guangdong Hospital of Traditional Medicine, Zhuhai, China
Former Members of the Editorial Advisory Board
Hui-Juan Shi, Ph.D., Institute of Planned Parenthood Research. Shanghai, China. (2017-2022)
Associate Editorial Advisory Board:
Mudassar Iqbal, Ph.D. The Kansas University, Lawrence.
ArunSundar MohanaSundaram, PhD. Sathyabama Institute of Science & Technology, Tamilnadu, India.
Saira Shahnaz, Ph.D. The Kansas University, Lawrence, KS
We are also constantly looking for guest editors who wish to compile a theme issue on a special subtopic in Translational Medicine
This may be particularly interesting for workshop and conference organizers putting together a grant-funded event (eg, with invited experts) on an translatiuonal medicine-related topic. AJTM can then be used as a dissemination vehicle. (Funding through grants or other sources is usually required and should be budgeted for in grant proposals. Letters of support are available from the AJTM editor.
The task of the guest editor(s) is generally to solicit manuscripts from colleagues concerning the selected topic,
to select peer-reviewers for incoming manuscripts,
to make decisions (together with the editorial board) on article revisions and acceptance, and to write an editorial for the theme issue to secure funding to sponsor the AJTM for published papers (usually in the $10-20k range).
Alternately, the abstracts of the conference may be published in a supplement, with selected full papers published later in a theme issue or in regular AJTM issues.
Xiaofang Shen American Journal of Translational Medicine
Jianping Yuan American Journal of Translational Medicine
Jian-Ming Wei American Journal of Translational Medicine
List of Reviewers:
Zia Choudhry, MD, Ph.D. Purdue Pharma. USA
Shweta Garg, Ph.D. National Diary Research Institute, India
Yong-Zhang Qin, MD Gannan Medical University Hospital, Ganzhou, China
Yan Yang, Ph.D. MD Anderson Cancer Center, Huston, TX. USA
Editorial board members must be peers whose judgment is highly regarded within the journal’s main discipline, or their decisions may not be regarded as valid. Publication number and academic aptitude are the top factors for editorial board membership.
Editorial board meetings
Editorial board meetings are useful opportunities to meet with some or all of the editorial board members to brief them on issues, take questions and also gain ideas for policies and upcoming journal editions. They can be done face to face, or via telephone or video conferencing.
We normally organize an Editorial board meeting annually in Hawaii.
Where board meetings are not possible, try to arrange to meet with board members on an individual basis at conferences or other events. Meeting board members is a key way of networking and building and strengthening the relationship with your editorial board.
Responsibilities of the Editorial Board
The Editorial Board should assist in a variety of aspects of running the journal. Their responsibilities may include (but are not limited to):
1. Providing scientific expertise for the journal
2. Submitting articles
3. Administering peer review or serving as a peer reviewer
4. Helping the journal to attract high-quality manuscripts, for example by promoting the journal at relevant conferences
5. Providing feedback and suggesting improvements for the journal
6. Suggesting topics and authors for commissioned reviews and commentaries
Maintaining the Editorial Board
In our policy, an Editorial Board should not be static; it is good practice to review the contributions and performance of each Board member every couple of years, and then take the opportunity to:
1. Restructure the Board, perhaps giving more active members increased responsibility
2. Give less active members the chance to step down, creating vacancies for new members (this is common practice and should not cause offense)
3. Thank all continuing members for their ongoing contributions; you may also wish to ask them to suggest new colleagues who might be suitable for the Board